Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

VINC

Vincerx (VINC)

Vincerx Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:VINC
日付受信時刻ニュースソース見出しコード企業名
2024/05/3010 : 12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VINCVincerx Inc
2024/05/3010 : 03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VINCVincerx Inc
2024/05/2905 : 38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VINCVincerx Inc
2024/05/2905 : 36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VINCVincerx Inc
2024/05/2905 : 36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VINCVincerx Inc
2024/05/2905 : 35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VINCVincerx Inc
2024/05/2905 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VINCVincerx Inc
2024/05/1505 : 24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VINCVincerx Inc
2024/05/1505 : 21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VINCVincerx Inc
2024/05/1505 : 15GlobeNewswire Inc.Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:VINCVincerx Inc
2024/04/2613 : 27GlobeNewswire Inc.Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and WarrantsNASDAQ:VINCVincerx Inc
2024/04/2605 : 01GlobeNewswire Inc.Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and WarrantsNASDAQ:VINCVincerx Inc
2024/04/0905 : 30GlobeNewswire Inc.Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024 NASDAQ:VINCVincerx Inc
2024/04/0121 : 00GlobeNewswire Inc.Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024NASDAQ:VINCVincerx Inc
2024/03/3004 : 20GlobeNewswire Inc.Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate UpdateNASDAQ:VINCVincerx Inc
2024/03/0910 : 08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VINCVincerx Inc
2024/03/0910 : 04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VINCVincerx Inc
2024/03/0606 : 31GlobeNewswire Inc.Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024NASDAQ:VINCVincerx Inc
2024/01/1620 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VINCVincerx Inc
2023/10/1322 : 12GlobeNewswire Inc.New to The Street Airs Televised Corporate Interviews Episodes 521 and 522 as Sponsored Programming on Bloomberg TV and The Fox Business NetworkNASDAQ:VINCVincerx Inc
2023/10/0622 : 30GlobeNewswire Inc.New to The Street Announces TV Corporate Appearances, broadcasting Episode 518 on Newsmax and Episode 519 on FOX Business Network, Airings start on Saturday, October 7, 2023, at 3:30 PM ETNASDAQ:VINCVincerx Inc
2023/09/1605 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VINCVincerx Inc
2023/08/1505 : 09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VINCVincerx Inc
2023/08/1107 : 27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VINCVincerx Inc
2023/08/0720 : 02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VINCVincerx Inc
2023/08/0720 : 01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VINCVincerx Inc
2023/06/2105 : 07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VINCVincerx Inc
2023/05/3105 : 01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VINCVincerx Inc
2023/05/1205 : 02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VINCVincerx Inc
2023/04/1305 : 14Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:VINCVincerx Inc
 Showing the most relevant articles for your search:NASDAQ:VINC